baber/WOPTO huggingface dataset:
Patent CZ-300476-B6 (CZ)
Title: Sectional gate
Inventor: HOERMANN THOMAS J
IPC: E05F15/00
Filed: 2002-04-25
Abstract: In the present invention, there is disclosed a sectional gate with a gate wing (10) that can be displaced between a closed position and an open position along a path prescribed by a guide rail assembly (20), wherein this guide rail assembly (20) comprises two guide rails (20), which are placed parallel, and each having two linear sections that are interconnected by an arched section (22). The gate wing (10) is provided with another guide assembly, that is placed between the guiding rails (20), for guiding the motion of the gate wing (10) alongside the arched section of a given trajectory, with fixed first contact element (44), which has a contact surface cooperative with a gate wing (10) edge for guiding the gate wing (10) motion, which edge is during opening in frontal position and during closing is pressed via a sliding contact diagonally downwards by the said contact surface.
Patent BR-PI0207800-B8 (BR)
Inventor: ANTONINO LANCI
IPC: A61F2/00
Filed: 2002-03-04
Abstract: A method for locating a material having thermoplastic properties in pores of bone tissue includes providing a pin having the material having thermoplastic properties and a core, wherein the material having thermoplastic properties is arranged on the circumferential surface of the core constituting an outer region of the pin. An opening is provided in the bone tissue, and the pin is positioned at least partly in the opening. The outer region of the pin is then impinged with mechanical vibration energy for a time sufficient for liquefying at least part of the material having thermoplastic properties, and, in a liquefied state, pressing it into the pores of the bone tissue surrounding the opening. The vibration energy is stopped for a time sufficient for re-solidification of the liquefied material, and then the core is removed.
Patent BR-PI0305913-B8 (BR)
Title: processos de obtenção de biflavonóides, atividades fotoprotetora, antioxidante, antiinflamatória e antienvelhecimento e seu uso em fármacos, nutracêuticos e cosméticos.
Inventor: LYDIA FUMIKO YAMAGUCHI
IPC: A61Q19/08
Filed: 2003-12-12
Abstract: "processos de obtenção de biflavonóides, atividades fotoprotetora, antioxidante, antiinflamatória e antienvelecimentos e seu uso em fármacos, nutracêuticos e cosméticos". refere-se a presente invenção a processos de obtenção de uma fração de biflavonóides de folhas de araucaria angustifolia, atividades fotoprotetora, antioxidante, antiinflamatória e antienvelhecimento e seu uso na fabricação de cosméticos e medicamentos úteis na fotoproteção, antioxidantes, antiinflamatórios e antienvelhecimento. mais especificamente, um dos processos de obtenção da fração de biflavonóides compreende as seguintes etapas: a) coleta de partes frescas da planta araucaria angustifólia; b) secagem das partes da araucaria angustifólia em estufa, a uma temperatura que varia entre 30 e 70,<198>c; c) moagem da planta seca, em moinho de facas tigre até uma granulometria de 2 a 6 mesh; d) maceração do pó obtido, numa temperatura entre 30 e 70<198>c, com etanol ou qualquer solvente de polaridades semelhantes, por 2 a 6 dias; e) preparo do extrato através da filtragem da solução obtida por maceração com papel de filtro seguida de concentração sob pressão reduzida a uma temperatura de 40 <sym> 20 <198>c; até reduzir a 1/3 do volume inicial; f) precipitação da fração de biflavonóides, através da adição ao extrato obtido de 1 a 3 l de água, seguida de evaporação a uma temperatura entre 30 e 70<198>c, à pressão reduzida para retirada do solvente; g) centrifugação ou decantação do precipitado resultante, para separar a fração de biflavonóides do sobrenadante, seguida da secagem do sólido obtido a temperatura de 25 <sym> 20 <198>c; h) caracterização da fração de bifiavonóides por cromatografia líquida de alta eficiência, cromatografia líquida de alta eficiência acoplada a espectrometria de massas, cromatografia planar e ressonância magnética nuclear; i) identificação dos componentes da fração de bifiavonóides utilizando-se padrões estabelecidos como comparação.
Patent EP-1217101-B8 (EP)
Inventor: BUIRGE ANDREW W
IPC: A61M25/00
Filed: 1995-04-26
Granted: 2006-02-01
Abstract: Collagen applied to a vascular stent for increasing the biocompatibility of the stent on implantation and method of treatment
Patent EP-1543884-B8 (EP)
Inventor: HORNSBY JAMES RUSSEL
IPC: B05B15/02
Filed: 2004-05-27
Granted: 2009-04-08
Abstract: The present invention is a dispenser adapted to couple to a fluid container (4) having an opening surrounded by a neck (22). The dispenser comprises a cap (14), a dispensing head (3), an energy source (24), and a conduit (18). The cap (14) is adapted to seal the opening fluid tight when the dispenser is coupled to the container (4). The dispensing head (3) is pivotably secured to the cap (14) and includes a fluid pump (34), a motor (30) adapted to power the pump (34), a trigger (10) adapted to actuate the motor (30), and a nozzle orifice in fluid communication with a discharge end of the pump (34). The energy source (24) is electrically connected to the motor (30) and extends inside the container (4). The conduit has a first end in fluid communication with an intake end of the pump (34) and a second end inside the container (4).
Patent EP-2310554-B8 (EP)
Inventor: TIXHON ERIC
IPC: C03C17/00
Filed: 2009-07-16
Granted: 2012-04-11
Abstract: The process comprises introducing or rolling a substrate in a reaction chamber (6) in which two electrodes (4, 10) are placed, where a dielectric barrier is positioned between the electrodes, generating a high frequency voltage to generate a plasma (12) between the electrodes, operating an adjustable inductor (L) arranged in parallel with own installation inductor generating voltage to reduce the phase difference between voltage and the generated current, and introducing a mixture (8) of which the composition is contacting the plasma into the reaction chamber. The process comprises introducing or rolling a substrate in a reaction chamber (6) in which two electrodes (4, 10) are placed, where a dielectric barrier is positioned between the electrodes, generating a high frequency voltage to generate a plasma (12) between the electrodes, operating an adjustable inductor (L) arranged in parallel with own installation inductor generating voltage to reduce the phase difference between voltage and the generated current, introducing a mixture (8) of which the composition is contacting the plasma into the reaction chamber, adjusting the voltage and/or frequency provided by the generator circuit and/or the value of the adjustable inductor at the beginning or during the process to obtain optimal characteristics of reaction, and maintaining the substrate in the chamber for a sufficient time to obtain a layer of desired thickness on the surface. The mixture is decomposed and generates species to deposit a layer on the substrate. The process further comprises adjusting the voltage and/or the frequency provided by the circuit generator and/or the value of the inductor to enhance the harmonic production extending the time during which voltage remains greater than the value of maintaining the electric charge, and changing the position and/or the configuration of an electrode to obtain the optimal characteristics of the reaction. The harmonics is enhanced in the order of 3-5. The chamber is opened or closed at its two ends, and comprises an inlet area and an outlet area for the substrate. The substrate insulates and forms a dielectric barrier and electrode. The mixture is introduced into the reaction chamber in the form of a reactive gas, a liquid reagent, and a reactive powder. An independent claim is included for an installation for depositing a layer on a substrate.
Patent EP-2223995-B8 (EP)
Inventor: SCHUMANN DIRK
IPC: C11D3/18
Filed: 2008-09-19
Granted: 2018-06-13
Abstract: Cleaning agent comprises a microemulsion or a fluid nanophase system and the components of (a) at least one water-insoluble substance having a solubility in water of less than 4 g per liter; (b) at least one amphiphile substance of n-propyl chloroacetate (nP-MCA); (c) at least one anionic-, cationic-, amphoteric- and/or non-ionic-surfactants; and (d) water and/or a water-soluble solvent having hydroxyl functionality and optionally additives. Cleaning agent comprises a microemulsion or a fluid nanophase system and the components of (a) at least one water-insoluble substance having a solubility in water of less than 4 g per liter; (b) at least one amphiphile substance of n-propyl chloroacetate (nP-MCA), which has no tenside structure and does not form structures on its own, and has a solubility in water or oil of 4-1000 g per liter and preferably does not accumulate at the oil-water boundary, with the proviso that nP-MCA is not selected from 2-ethyl-1,3-hexanediol, 2-methyl-2,4-pentanediol, 2-(n-butyl)-2-ethyl-1,3-propanediol and/or 1,2-diols; (c) at least one anionic-, cationic-, amphoteric- and/or non-ionic-surfactants; and (d) water and/or a water-soluble solvent having hydroxyl functionality and optionally additives. Independent claims are included for: (1) preparation of the cleaning agent, comprising providing water or a solvent with hydroxyl-functionality and dissolving an anionic, cationic, amphoteric and/or non-ionic surfactants at 10-90[deg] C under agitating, adding water-insoluble substance parallelly or after surfactant-addition and then transferring the developed emulsion through the addition of a further amphiphile substance and nP-MCA in an optically transparent microemulsion or a nanophase system and optionally adding auxiliary materials at the end of the mixture procedure; (2) removing unwanted dyes and lacquers from surfaces, comprising applying the cleaning agent on the unwanted dye or the lacquer, impacting and subsequently removing the dye or the lacquer with water, where the impact time at: the graffiti-remover is 10 seconds to 30 minutes; the paint remover is 20 minutes to 3 hours; and the nail polish remover is 3-30 seconds; and (3) removing dirt (soot, fat, oils, silicone, fine particulate and/or resin) from surfaces, of cosmetics or for the hair discoloration, comprising applying the cleaning agent on the dirt to remove the cosmetic or to discolorize the hairs, impacting and subsequently removing the dirt, agent or dye with water, where the impact time at: the dirt remover is 10 seconds to 3 hours; the cosmetic remover is 10 seconds to 30 minutes; and the hair discolorizer is 2 minutes to 24 hours.
Patent EP-1123531-B8 (EP)
Inventor: SOEHNE PETER
IPC: G06F21/24
Filed: 1999-10-06
Granted: 2010-07-14
Abstract: The copy protection system is a combination of a signature method and a coding or encryption method that uses a variable key. The data set is written only onto a predetermined device and it is released to a host for reading and deciphering only upon proper authorization. Copying of the encrypted data set is entirely useless, because the dataset is signed with a unique identification (e.g. the serial number) of the device.
Patent BR-PI0705344-B8 (BR)
Title: retoscópio
Inventor: JOSÉ JOAQUIM RIBEIRO DA ROCHA
IPC: A61B1/31
Filed: 2007-10-26
Abstract: retoscópio e seu uso para excisão transanal endoscópica. a presente invenção refere-se a um retoscópio cirúrgico compreendendo um cilindro de 4 cm de diâmetro de extremidade chanfrada com orifícios para fixação na pele, um dispositivo para o encaixe do cabo de fibra óptica para iluminação do campo e um mandril para a introdução anal. adicionalmente, o presente pedido destina-se ao uso do retoscópio para excisão transanal endoscópica.
Patent BR-PI0718176-B8 (BR)
Title: formulação semissólida de liberação prolongada e controlada, processo para a preparação da composição farmacêutica semissólida
Inventor: ANNE-PAULA DE SOUSA DELGADO
IPC: A61K38/30
Filed: 2007-10-26
Abstract: formulação semissólida de liberação prolongada e controlada, processo para a preparação da composição farmacêutica semissólida. a invenção atual refere-se a uma formulação semissólida parenteral de liberação prolongada e controlada composta de um oligômero capeado na extremidade e uma substância ativa sem qualquer agente de redução de viscosidade suplementar ou excipiente.
Patent BR-PI0809998-B8 (BR)
Title: composto de imidazo[1,2-a] piridina como inibidores do receptor tirosina quinase, seus usos, seus processos de preparação e composições farmacêuticas
Inventor: FREDRIK P MARMSÄTER
IPC: A61K31/33
Filed: 2008-03-27
Abstract: composto de imidazol [1,2-a] piridina como inibidores do receptor tirosina quinase e processo para a preparação dos referidos compostos . composto da fórmula i: em que a, b, r1, r1a, r2, r3, r4, r5, r6, r7, e r8 têm os significados dados no relatório descritivo, são inibidores do receptor de tirosina úteis no tratamento de doenças mediadas por receptor de tirosina quinases da classe 3 e da classe 5. compostos particulares desta invenção foram também descobertos ser inibidores de pim-1.
Patent BR-PI9800337-B8 (BR)
Inventor: CINDY DAWN CHRISTOPHERSON
IPC: C12N15/49
Filed: 1998-01-16
Abstract: The present invention provides improved primers for the polymerase chain reaction (PCR) amplification of a nucleic acid sequence from the gag gene of the human immunodeficiency virus type 1 (HIV-1). The primers and amplification methods of the invention enable the detection of all HIV-1 group M isolates with nearly uniform efficiency.
Patent AU-2007287205-B8 (AU)
Title: Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses
Inventor: BRANDIS ALEXANDER
IPC: C07K7/06
Filed: 2007-08-23
Granted: 2013-08-15
Abstract: Conjugates of porphyrin, chlorophyll and bacteriochlorophyll photosensitizers with RGD-containing peptides or RGD peptidomimetics are provided that are useful for photodynamic therapy (PDT), particularly vascular-targeted PDT (VTP), of tumors and nonneoplastic vascular diseases such as age-related macular degeneration, and for diagnosis of tumors by different techniques.
Patent BR-112012018243-B8 (BR)
Title: Pó de pulverização e método para fabricar esse pó
Inventor: MITCH DORFMAN
IPC: B32B5/16
Filed: 2011-01-25
Abstract: COMPOSIÇÃO ABRASÍVEL E MÉTODO DE FABRICAÇÃO.  A presente invenção refere-se a um pó de pulverização térmica tendo um primeiro componente A mecanicamente misturado com um segundo componente B, em que o primeiro componente A é um metal ou compósito metálico, preferivelmente pelo menos um entre ABN cladeado com Ni-Cr-Al-HBN cladeado com Ni-Cr-Al, pó de nitreto de boro hexagonal aglomerado com ligante orgânico cladeado com Ni-Cr-Al, pó de nitreto de boro hexagonal aglomerado com ligante inorgânico cladeado com Ni-Cr-Al, um pó tipo M- CrAIY em que M é pelo menos um entre Ni, Co, Fe, e em que o componente B é um polímero cladeado com pelo menos um entre níquel, ligas de níquel, ligas de níquel cromo, ligas de níquel cromo alumínio, ligas de níquel alumínio, cobalto e ligas de cobalto. O resultado é um pó de pulverização térmica de quatro fases distintamente diferentes, tornando o pó uma mistura de quatro fases.
Patent BR-112012020999-B8 (BR)
Title: método para reparar um membro compreendendo um plástico reforçado com fibra
Inventor: ATSUMI TANAKA
IPC: B29C73/02
Filed: 2011-01-26
Abstract: método para reparar um membro compreendendo um plástico reforçado com fibra é descrito um método para reparar um membro compreendendo uma resina reforçada com fibra. dito método pode facilmente e com baixo custo reparar um orifício transpassante. quando a reparação de um orifício transpassante (20), um orifício temporário (11) é formado, uma folha de tecido (30) compreendendo fibras reforçadas é rolada para um cilindro e inserida em um orifício temporário (11), a folha de tecido é impregnada com uma resina, a resina é enrijecida, e um novo orifício transpassante (20) é formado.
Patent BR-112017021607-B8 (BR)
Title: Método de determinação de lente oftálmica e lente oftálmica
Inventor: MARIE JARROUSSE
IPC: G02C7/02
Filed: 2016-04-08
Abstract: LENTE OFTÁLMICA E MÉTODO PARA A DETERMINAÇÃO DESSA LENTE OFTÁLMICA. O invento se relaciona com um método de seleção de uma lente oftálmica adequada para a correção de pelo menos uma deficiência óptica de um olho de um usuário que observa um écran. De acordo com o invento, o método compreende as etapas de: - determinação de pelo menos uma característica de postura do usuário observando o referido écran, - determinação de um valor de potência dióptrica associado à referida zona de visão permitindo ao usuário, ao usar a lente oftálmica, ter uma leitura mais fácil do referido écran, - determinação de pelo menos uma característica de meios de filtragem para ajustar a exposição à luz do usuário ao referido écran, e - determinação da zona de visão com base no valor de potência dióptrica, na característica de postura do usuário e na característica de meios de filtragem para que o conforto de visão do usuário seja otimizado ao usar a lente oftálmica enquanto observa um écran.
Patent BR-122018015003-B8 (BR)
Inventor: GARY MICHAEL KSANDER
IPC: A61P9/08
Filed: 2003-01-16
Abstract: The invention relates a pharmaceutical composition comprising a combination of i the AT 1- antagonist valsartan or a pharmaceutically acceptable salt thereof and ii a NEP inhibitor or a pharmaceutically acceptable salt thereof and optionally a pharmaceutically acceptable carrier and to a method for the treatment or prevention of a condition or disease selected from the group consisting of hypertension, heart failure such as acute and chronic congestive heart failure, left ventricular dysfunction and hypertrophic cardiomyopathy, diabetic cardiac myopathy, supraventricular and ventricular arrhythmias, atrial fibrillation, atrial flutter, detrimental vascular remodeling, myocardial infarction and its sequelae, atherosclerosis, angina whether unstable or stable, renal insufficiency diabetic and non­-diabetic, heart failure, angina pectoris, diabetes, secondary aldosteronism, primary and secondary pulmonary hypertension, renal failure conditions, such as diabetic nephropathy, glomerulonephritis, scleroderma, glomerular sclerosis, proteinuria of primary renal disease, and also renal vascular hypertension, diabetic retinopathy, the management of other vascular disorders, such as migraine, peripheral vascular disease, Raynaud's disease, luminal hyperplasia, cognitive dysfunction such as Alzheimer's, glaucoma and stroke, comprising administering a therapeutically effective amount of the pharmaceutical composition to a mammal in need thereof.
Patent EP-1645574-B9 (EP)
Title: Procede de production en continu d'acetate d'ethylene vinyle et systeme de reaction
Inventor: TSAI JING-JIN
IPC: C08F210/02
Filed: 2003-07-01
Granted: 2009-10-21
Abstract: La présente invention concerne un procédé de production en continu d'un copolymère d'acétate d'éthylène vinyle consistant à soumette de l'éthylène et de l'acétate de vinyle à une réaction de copolymérisation en solution, caractérisé en ce que la partie phase gazeuse de la réaction de polymérisation est reliée à une tour d'élimination des impuretés et, après avoir été lavée au moyen du solvant utilisé pour la réaction de polymérisation, circule dans le système de réaction où se produit l'élimination des impuretés. Cette invention concerne également un système de réaction utilisé pour la production en continu d'un copolymère d'acétate d'éthylène vinyle, comprenant un réacteur pour la copolymérisation de l'éthylène de l'acétate de vinyle, une tour de récupération reliée audit réacteur, un conduit de décharge du copolymère d'acétate d'éthylène vinyle raccordé à la partie inférieure de ladite tour de récupération, et une tour d'élimination des impuretés raccordée au somment dudit réacteur qui lave les impuretés produites par la réaction.
Patent EP-0916657-B9 (EP)
Inventor: YANO SHINGO
IPC: A61K31/40
Filed: 1993-09-08
Granted: 2006-05-17
Abstract: An optically active form of a compound represented by the following formula (II) below is useful as an agent for treating hyperlipidemia which has an activity to inhibit the synthesis of fatty acids and an activity to inhibit the synthesis of cholesterol <CHEM> wherein R' is a hydrogen atom or a lower alkyl group such as an alkyl group having 1 to 6 carbon atoms, and a synthesis method for same is described.
Patent EP-0991923-B9 (EP)
Inventor: JENSEN MORTEN J
IPC: G01J1/46
Filed: 1998-06-26
Granted: 2007-10-17
Abstract: A method and apparatus for measuring very low light signals including integrating a signal from a photo diode, avalanche photo diode, photomultiplier tube or the like, digitally sampling the integrator output more than two times during each integration period, fitting a curve to the multiple digitized readings to calculate the integration slope for each integration period and determining the original signal from the calculated integration slope.
Patent BE-1027225-B9 (BE)
Title: Système de mesure par déflectométrie
Inventor: ANTOINE PHILIPPE
IPC: G02B27/54
Filed: 2019-04-24
Granted: 2021-02-03
Abstract: Système de mesure (200) par déflectométrie d’un échantillon (2) comprenant : - une source (10) pour générer un faisceau lumineux en un plan source (105) ; - un module d’illumination (19) pour former un faisceau d’illumination (9) comprenant : o un premier élément optique convergent (18) ; o un premier élément optique de sélection (16) présentant une première ouverture (160) ; - des moyens de modulation optique matriciels (30) en réflexion, pour former un motif (7), ladite première ouverture (160) étant configurée pour contrôler les angles dudit faisceau d’illumination (9) sur lesdits moyens de modulation optique matriciels (30) en réflexion ; - une lentille de Schlieren (20) pour obtenir un codage angle-intensité dudit motif (7) sur l’échantillon (2) ; - des moyens d'imagerie (40) et de détection (50) pour détecter une image dudit échantillon (2).
Patent EA-036164-B9 (EA)
Title: Pipe joint
Inventor: MANNING JOHN PATRICK
IPC: F16L37/14
Filed: 2016-10-25
Abstract: A pipe joint (1) for joining a first and a second conduit sections (10, 20) by means of a receiving recess (12) on one end of the first conduit section (10), wherein the joint (1) a first groove (60) formed in an internal wall (14) of the receiving recess (12), the first groove (60) being accessible via a transverse insertion passage (70); a plurality of second grooves (62) axially spaced apart from one another, formed in the external wall of the connection end of the second conduit section (20); and an elongate flexible anchoring strip (50), comprising a plurality of anchoring portions (52, 54) axially spaced apart from one another and being configured to be placeable in a respective one of the second grooves (62); wherein, when the first and second grooves (60, 62) have been brought into alignment, upon insertion of the connection end of the second conduit section (20) into the receiving recess (12), the anchoring strip (50) is inserted from the outside of the first conduit section (10) into the first groove (60) and the plurality of second grooves (62) so as to be seated in and between them, thereby the first and second conduit sections (10, 20) are united and axially immovable relative to each other.
Patent AU-2001274290-B9 (AU)
Title: Fused azepine derivatives and their use as antidiuretic agents
Inventor: ASHWORTH DOREEN MARY
IPC: A61K31/5517
Filed: 2001-06-21
Granted: 2006-06-29
Abstract: Compounds according to general formulae (1 and 2), wherein G<SUP>1 </SUP>is an azepine derivative and G<SUP>2 </SUP>is a group according to general formulae (9-11) are new. Compounds according to the invention are vasopressin V<SUB>2 </SUB>receptor agonists. Pharmaceutical compositions of the compounds are useful as antidiuretic agents